𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Interferon-alpha and the pathogenesis of myeloproliferative disorders

✍ Scribed by IA Voutsadakis

Publisher
Springer US
Year
2000
Tongue
English
Weight
842 KB
Volume
17
Category
Article
ISSN
1357-0560

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

ChemInform Abstract: The Role of Interfe
ChemInform Abstract: The Role of Interferon-Alpha in the Treatment of Myeloproliferative Disorders
✍ Claudia Fiorani; Stefania Tonelli; Barbara Casolari; Stefano Sacchi πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons βš– 25 KB πŸ‘ 2 views

## Abstract ChemInform is a weekly Abstracting Service, delivering concise information at a glance that was extracted from about 100 leading journals. To access a ChemInform Abstract of an article which was published elsewhere, please select a β€œFull Text” option. The original article is trackable v

Immunologic dysfunction in the myeloprol
Immunologic dysfunction in the myeloproliferative disorders
✍ Nicholas J. Dibella; George L. Brown πŸ“‚ Article πŸ“… 1978 πŸ› John Wiley and Sons 🌐 English βš– 546 KB

Forty patients with various types of myeloproliferative disorders were evaluated immunologically. Serum immunoglobulin levels were within the normal range in most patients and no monoclonal gammopathies were detected. Serum C'3 levels were decreased in 19 of 40 (48%) patients. The response of periph

The V617F JAK2 mutation and the myelopro
The V617F JAK2 mutation and the myeloproliferative disorders
✍ Melanie J Percy; Mary Frances McMullin πŸ“‚ Article πŸ“… 2005 πŸ› John Wiley and Sons 🌐 English βš– 70 KB

## Abstract The discovery this year of a single mutation in the Janus Kinase (__JAK__)‐2 gene in a high percentage of cases of polycythaemia vera (PV), essential thrombocythaemia (ET) and myelofibrosis suggests that it maybe the underlying molecular mechanism for these disorders. Different approach